ITC Overrules Novo's Objection To Baxter Expert Disclosure
The International Trade Commission on Monday denied Novo Nordisk Inc.'s objection to revealing confidential business information to Baxter International Inc.'s technical expert in a patent dispute over recombinant factor VIII products...To view the full article, register now.
Already a subscriber? Click here to view full article